Consequences of ddI-induced reduction of acute SIVmac251 virus load on cytokine profiles in cynomolgus macaques

Barcellini, 1994, TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients, AIDS, 8, 757, 10.1097/00002030-199406000-00006 Barker, 1995, Effects of TH1 and TH2 cytokines on CDS+ cell response against human immunodeficiency virus : implications for long-term survival, 92, 11135 Barré-Sinoussi, 1983, Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS), Science, 220, 868, 10.1126/science.6189183 Benveniste, 1996, Comparative IL-2/IFN gamma and IL-4/IL-10 responses during acute infection of macaques inoculated with attenuated nef-truncated or pathogenic SIVmac251, 93, 3658 Benveniste, 1996, Interleukin-1β, interleukin-6, tumor necrosis factor alfa and interleu-kin-10 responses in PBMC of cynomolgus macaques during acute infection with SIVmac251, AIDS Res. Hum. Retroviruses, 12, 241, 10.1089/aid.1996.12.241 Benveniste, 1996, Cytokine mRNA levels in unmanipulated (ex vivo) and in vitro stimulated monkey PBMCs using a semi-quantitative RT-PCR and high sensitivity fluorescence-based detection strategy, Cytokine, 8, 32, 10.1006/cyto.1996.0005 Benveniste, 1998, Comparing EL-6, TNFα, and EL-1β responses to acute infection with attenuated nef-truncated or pathogenic SEVmac251 in macaque peripheral blood mononuclear cells, J. Acquired Immune Defic. Syndr., 18, 389, 10.1097/00042560-199808010-00012 Borghi, 1995, Induction of interleukin-10 by human immunodeficiency virus type 1 and its gp120 protein in human monocytes/macrophages, J. Virol., 69, 1284, 10.1128/JVI.69.2.1284-1287.1995 Caruso, 1995, CD4+ and CD8+ lymphocytes of patients with AIDS synthesize increased amounts of Interferon gamma, J. AIDS Hum. Retrovir., 10, 462 Chakrabarti, 1995, Limited viral spread and rapid immune response in lymph nodes of macaques inoculated with attenuated simian immunodeficiency virus, Virology, 213, 535, 10.1006/viro.1995.0026 Chakrabarti, 1994, Variable course of primary simian immunodeficiency virus infection in lymph nodes : relation to disease progression, J. Virol., 68, 6634, 10.1128/JVI.68.10.6634-6643.1994 Chéret, 1996, Cytokine mRNA expression in mononuclear cells from different tissues during acute SIVmac251 infection of macaques, AIDS Res. Hum. Retroviruses, 12, 1263, 10.1089/aid.1996.12.1263 Chollet-Martin, 1994, Comparison of plasma cytokine levels in african patients with HEV-1 and HIV-2 infection, AIDS, 8, 879, 10.1097/00002030-199407000-00003 Clark, 1993, The acute retroviral syndrome and the pathogenesis of HIV-1 infection, 5, 149 Clerici, 1993, A TH1→TH2 switch is a critical step in the etiology of HIV infection, Immunol. Today, 14, 107, 10.1016/0167-5699(93)90208-3 Clerici, 1989, Detection of three distinct patterns in asymptomatic, human immunodeficiency virus-seropositive patients: independence of CD4+ cell numbers and clinical staging, J. Clin. Invest., 84, 1892, 10.1172/JCI114376 Connolly, 1991, Phase I study of 2′-3′-dideoxyinosine administered orally twice daily to patients with AIDS or AIDS-related complex and hematologic intolerance to zidovudine, Am. J. Med., 91, 471, 10.1016/0002-9343(91)90182-W Cooley, 1990, Once-daily administration of 2′,3′-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a Phase I trial, N. Engl. J. Med., 322, 1340, 10.1056/NEJM199005103221902 Daniel, 1985, Isolation of a T-cell tropic HTLV-III-like retrovirus from macaques, Science, 228, 1200, 10.1126/science.3159089 De Waal Malefyt, 1992, Interleukin-10, Curr. Opinion Immunol., 4, 314, 10.1016/0952-7915(92)90082-P Desrosiers, 1990, The simian immunodeficiency viruses, Annu. Rev. Immunol, 8, 557, 10.1146/annurev.iy.08.040190.003013 Dittmer, 1994, Early helper T-cell dysfunction in simian immunodeficiency virus but not in human immunodeficiency virus type-2-infected macaques, J. Med. Primatol., 23, 298, 10.1111/j.1600-0684.1994.tb00287.x Dittmer, 1995, Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus, Virology, 212, 392, 10.1006/viro.1995.1496 Faulds, 1992, Didanosine: a review of its antiviral activity, pharmacokinetic properties and therapeutic potential in human immunodeficiency virus infection, Drugs, 44, 94, 10.2165/00003495-199244010-00008 Gazinelli, 1992, CD4+ subset regulation in viral infection: preferential activation of Th2 cells during progresion of retrovirus-induced immunodeficiency in mice, J. Immunol., 148, 182, 10.4049/jimmunol.148.1.182 Graziosi, 1994, Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals, Science, 265, 248, 10.1126/science.8023143 Heeney, 1995, AIDS: a disease of impaired Th-cell renewal?, Immunol. Today, 16, 515, 10.1016/0167-5699(95)80043-3 Heinzel, 1993, Recombinant interleukin-12 cures mice infected with Leshmania major, J. Exp. Med., 177, 1505, 10.1084/jem.177.5.1505 Henrard, 1995, Virologic and immunologic characterisation of symptomatic and asymptomatic primary HIV-1 infection, J. AIDS Hum. Retrovir., 9, 305 Kärber, 1931, Beitrag zur kollektiven Behandlung pharmakologischer Reihenvesuche, Arch. Exp. Path. Pharmak., 162, 956, 10.1007/BF01863914 Keet, 1993, Predictors of rapid progression to AIDS in HIV-1 seroconverters, AIDS, 7, 51, 10.1097/00002030-199301000-00008 Koup, 1994, Temporal association of cellular immune response with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome, J. Virol., 68, 4650, 10.1128/JVI.68.7.4650-4655.1994 Lambert, 1990, 2′,3′-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trial, N. Engl. J. Med., 322, 1333, 10.1056/NEJM199005103221901 Le Grand, 1994, An animal model for antilentiviral therapy: effect of zidovudine on viral load during acute infection after exposure of macaques to simian immunodeficiency virus, AIDS Res. Hum. Retroviruses., 10, 1279, 10.1089/aid.1994.10.1279 Le Grand, 1992, AIDS vaccine developments, Nature, 355, 684, 10.1038/355684a0 Le Grand, 1992, Specific and non-specific immunity and protection of macaques against SIV infection, Vaccine, 10, 873, 10.1016/0264-410X(92)90052-L Letvin, 1985, Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III, Science, 230, 71, 10.1126/science.2412295 Levy, 1993, Pathogenesis of human immunodeficiency virus infection, Microbiol. Reviews, 57, 183, 10.1128/MR.57.1.183-289.1993 Maggi, 1994, Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells, Science, 265, 244, 10.1126/science.8023142 Marfaing-Koka, 1995, In vivo role of IL-6 on the viral load and on immunolog-ical abnormalities of HlV-infected patients, J. AIDS Hum. Retrovir., 11, 59 Meyaard, 1994, Changes in cytokine secretion patterns of CD4+ T-cell clones in human immunodeficiency virus infection, Blood, 84, 4262, 10.1182/blood.V84.12.4262.bloodjournal84124262 Orme, 1993, Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection, J. Immunol., 151, 518, 10.4049/jimmunol.151.1.518 Pearce, 1991, Down-regulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni, J. Exp. Med., 173, 159, 10.1084/jem.173.1.159 Poli, 1994, Interleukin-1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin-6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin-1 receptor antagonist., 91, 108 Romagnani, 1994, Role of TH1/TH2 cytokines in HIV infection, Immunol. Rev., 140, 73, 10.1111/j.1600-065X.1994.tb00865.x Roos, 1995, Serological, virological, and immunological studies in acute HIV-1 infection Rud, 1992, Infectious molecular clones of SIVmac32H: Nef deletion controls ability to reisolate virus from rhesus macaques, Vaccine, 92, 229 Saville, 1994, Interleukin-10 suppresses human immunodeficiency virus-1 replication in vitro in cells of the monocyte/inacrophage lineage, Blood, 83, 3591, 10.1182/blood.V83.12.3591.3591 Sheppard, 1991, The initial immune response to HIV and immune system activation determine the outcome of HIV disease, J. Acquir. Immune Defic. Syndr., 4, 704 Sinicco, 1993, Cytokine network and acute primary HIV-1 infection, AIDS, 7, 1167, 10.1097/00002030-199309000-00003 Sinicco, 1993, Risk of developing AIDS after primary acute HIV-1 infection, J. Acquir. Immune. Defic. Syndr., 6, 575 Sonza, 1996, Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes, J. Virol., 70, 3863, 10.1128/JVI.70.6.3863-3869.1996 Villinger, 1995, Comparative sequence analysis of cytokine genes from human and non-human primates, J. Immunol., 155, 3946, 10.4049/jimmunol.155.8.3946 Villinger, 1993, Qualitative and quantitative studies of cytokines synthetized and secreted by non-human primate peripheral blood mononuclear cells, Cytokine, 5, 469, 10.1016/1043-4666(93)90038-7 Wakrim, 1996, Superinfection of HIV-2-preinfected macaques after rectal exposure to a primary isolate of SIVmac251, Virology, 221, 260, 10.1006/viro.1996.0375 Weissman, 1995, IL-10 synergizes with multiple cytokines in enhancing HIV production in cells of monocytic lineage, J. AIDS Hum. Retrovir., 9, 442 Yamamura, 1991, Defining protective responses to pathogens: cytokine profiles in leprosy lesions, Science, 254, 277, 10.1126/science.1925582 Yasutomi, 1993, Simian immunodeficency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys, J. Virol, 67, 1707, 10.1128/JVI.67.3.1707-1711.1993 Yerly, 1995, Early and prolonged decrease of viremia in HIV-1-infected patients treated with didanosine, J. AIDS Hum. Retrovir., 8, 358 Yssel, 1991, Borrelia burgdorferi activates a T helper type 1-like T-cell subset in Lyme arthritis, J. Exp. Med., 174, 593, 10.1084/jem.174.3.593 Zou, 1997, Early cytokine and chemokine gene expression in lymph nodes of macaques infected with simian immunodeficiency virus is predictive of disease outcome and vaccine efficacy, J. Virol, 71, 1227, 10.1128/JVI.71.2.1227-1236.1997